By Ross Todd | August 12, 2022
The $61 million verdict that Dan Miller, Jonathan DeSantis and Derek Cohen landed in Chicago federal court last week stands to be trebled to more than $183 million under the False Claims Act.
By Ross Todd | July 15, 2022
Following a three-month bench trial last summer, a federal judge in West Virginia last week handed a major victor to defense teams for the three largest wholesale distributors of prescription painkillers led by Paul Schmidt of Covington & Burling, Enu Mainigi of Williams & Connolly and Robert Nicholas of Reed Smith.
By Ross Todd | July 14, 2022
The veteran trial star teamed with new partners Chantale Fiebig and Liz Ryan, who both joined the firm last year, to represent regional grocery and pharmacy chain Giant Eagle in the first bellwether trial involving pharmacy defendants in the national opioid MDL.
By Ross Todd | May 25, 2022
Paul Schmidt, Andrew Stanner and Laura Flahive Wu of Covington & Burling discuss the challenge of staying on top of the all-encompassing assignment that's called on 50 lawyers at any given time.
By Ross Todd | February 11, 2022
Despite objections from the U.S. Trustee, the SEC, the state of Rhode Island and others, Latham's Chris Harris and Betsy Marks were able to get judicial sign-off on the pharma company's reorganization plan, including a $1.7 billion settlement of opioid-related litigation.
By Ross Todd | January 7, 2022
The D.C. Circuit this week found that his clients, families of 395 Americans killed or injured in Iraq by the terrorist group Jaysh al-Mahdi, adequately alleged the companies aided and abetted the group by paying bribes to the country's ministry of health, which the group controlled.
By Ross Todd | November 19, 2021
Barbara Mullin of Patterson Belknap Webb & Tyler fended off a generic drug maker's patent challenge to Janssen's antipsychotic drug Invega Sustenna which has more than $1.5 billion in annual sales. The win means nearly 10 more years of patent protection for the drug.
By Ross Todd | November 5, 2021
The tentative decision from a judge in Orange County, California, was the first major win for drug companies facing trials across the country targeting their roles in the opioid crisis. Kirkland & Ellis, Hueston Hennigan, O'Melveny & Myers and Morgan, Lewis & Bockius represented the defendants.
By Ross Todd | August 27, 2021
Following a seven-day remote bench trial last year, Christopher Sipes, Erica Andersen, and Brianne Bharkhda of Covington & Burling got a ruling from a federal judge in Delaware this week finding the four patents covering cancer treatment Imbruvica were valid and infringed.
By Ross Todd | July 30, 2021
A federal jury in Oakland sided with Daralyn Durie, Eugene Novikov, Kira Davis and their client, Berkeley, California-based Plexxikon, finding that Novartis willfully infringed patents for the first FDA-approved targeted therapy for metastatic melanoma.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
Job Opportunity: Location: Prestigious Florida Law Firm seeks to hire a Business attorney with at least 5 years of experience for their Ft. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS